Secondaries private equity dealmaking fell off a cliff in the first half of the year as the coronavirus crisis saw deal value drop more than 56% compared to the same period in 2019, new research shows.
Buyout
Coronavirus
covid
Cross Industry
data
deal
direct
Distressed
Featured
Fund
Fundraising
General
Global
Industry Research
invest
investment
market
Pharma and Healthcare
private equity
report
Secondaries
Setter Capital
Software and Hi-Tech
Volatility
Secondaries private equity dealmaking falls apart due to Covid – but record fundraising leaves sector in rude health
Most Popular
